Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026
Same author

Age-related dry eye disease: Redefining a distinct subtype driven by aging.

The ocular surface·2026
Same author

Computed tomography assessment after out-of-hospital cardiac arrest resuscitation.

Resuscitation plus·2026
Same author

Selective decreases in regulatory B cell (Breg) subsets in active uveitis: IL-10+CD19+CD24hiCD38hiBreg in patients and B10 Breg in mice.

International immunology·2026
Same author

MIF-CD74 signaling drives immune modulation in medulloblastoma.

Neuro-oncology·2026
Same author

Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathies.

Research square·2026

Related Experiment Video

Updated: Oct 5, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.2K

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model.

Chantelle E Bowers1, Virginia L Calder1, John Greenwood1

  • 1UCL Institute of Ophthalmology, University College London.

Journal of Visualized Experiments : Jove
|January 31, 2022
PubMed
Summary

This study details a protocol for inducing Experimental Autoimmune Uveitis (EAU) in C57BL/6J mice, a key model for posterior uveitis. The method uses interphotoreceptor retinoid binding protein peptide and adjuvants for reproducible disease induction and assessment.

More Related Videos

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

2.8K
A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
09:42

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

Published on: June 7, 2017

11.6K

Related Experiment Videos

Last Updated: Oct 5, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.2K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

2.8K
A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
09:42

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

Published on: June 7, 2017

11.6K

Area of Science:

  • Ophthalmology
  • Immunology
  • Preclinical Research

Background:

  • Experimental Autoimmune Uveitis (EAU) is a critical animal model for human posterior uveitis.
  • EAU aids in studying intraocular inflammation mechanisms and therapeutic efficacy.

Purpose of the Study:

  • To provide a detailed protocol for EAU induction in C57BL/6J mice.
  • To outline methods for assessing disease severity and progression in this model.

Main Methods:

  • EAU induction via subcutaneous injection of IRBP1-20 peptide, Complete Freund's Adjuvant (CFA), and Mycobacterium tuberculosis, followed by Bordetella pertussis toxin.
  • Clinical assessment using fundoscopy, histological examination, and fluorescein angiography at key disease stages.
  • Utilizes C57BL/6J mice, a standard model organism susceptible to EAU.

Main Results:

  • The protocol enables reliable induction of EAU, mirroring human posterior uveitis.
  • Fundoscopy, histology, and angiography allow for quantitative assessment of disease severity and progression.
  • Demonstrates flexibility for use in various mouse strains and combination with therapeutic studies.

Conclusions:

  • This standardized EAU induction protocol facilitates reproducible research in uveitis.
  • The described assessment methods provide comprehensive data on disease phenotype and progression.
  • The model is valuable for evaluating novel anti-inflammatory therapies and understanding intraocular disease mechanisms.